|Year : 2008 | Volume
| Issue : 1 | Page : 92-93
West nile virus in the blood donors in UAE
M Alfaresi, A Elkoush
Department of Pathology and Laboratory Medicine, Microbiology Division, Zayed Military Hospital, Abu Dhabi, United Arab Emirates
|Date of Submission||28-Mar-2007|
|Date of Acceptance||02-May-2007|
Department of Pathology and Laboratory Medicine, Microbiology Division, Zayed Military Hospital, Abu Dhabi
United Arab Emirates
Source of Support: None, Conflict of Interest: None
|How to cite this article:|
Alfaresi M, Elkoush A. West nile virus in the blood donors in UAE. Indian J Med Microbiol 2008;26:92-3
West Nile virus (WNV) belongs to the family Flaviviridae , a large family of positive-strand RNA viruses with 3 main genera (flavivirus, hepacivirus and pestivirus). Among the more than 70 viruses in the genus flavivirus, several neurotropic and hepatotropic viruses that are important in human disease are transmitted by arthropods (dengue, Japanese encephalitis, yellow fever and tick-borne encephalitis). West Nile virus belongs to the Japanese encephalitis serocomplex, which also includes Japanese encephalitis and St Louis encephalitis, among others. 
WNV was associated with West Nile fever, a non-specific febrile illness that was found in several countries in Africa and the Middle East, either in epidemics or as an endemic mild febrile illness. The association with high rates of encephalitis and death is relatively new and suggests the presence of a new strain of virus. 
Birds are the main reservoir of WNV in nature; more than 200 species in the United States have been found to be infected. Several species of mosquitoes can acquire the virus after biting a bird with high-level viraemia and may then transmit it to the next animal they bite. Transmission between birds in the absence of mosquitoes has been documented in the laboratory, but whether this occurs under natural conditions remains unknown.  Many species of vertebrates can be infected by virus-carrying mosquitoes. Horses have a high mortality rate (30%); in contrast, cats and dogs are infected frequently, but the case-fatality rate is low. Humans typically do not develop high-level viraemia, so they are considered to be a dead-end for the virus under normal circumstances. However, transmission through organ transplantation or blood transfusion has been documented. One case of transmission through breast-feeding was reported, but the infant remained asymptomatic. 
The proportion of patients who develop disease after acquiring the virus is unknown. The commonly reported estimates (1 in 5 infected patients develops fever and 1 in 150 infected patients develops severe neurological disease) come from serological surveillance data from the New York epidemic.
Although the transmission of WNV virus by blood transfusion had not been reported before 2002, the findings of transient viraemia after infection and a high proportion of asymptomatic or mildly symptomatic infections suggested that this route of transmission might be possible. 
In August 2002, in response to theoretical concern that WNV could be transmitted through blood transfusions, the Food and Drug Administration and the CDC advised blood establishments and health departments to be alert for persons with WNV infection who had donated blood the week before their illness began and for persons with unexplained fever-associated meningitis or encephalitis that developed after the receipt of a blood transfusion. In response to these messages, on 30 August 2002, a state health department notified the CDC of the first suspected case of transfusion-transmitted WNV in a woman who had received blood and blood products related to an obstetrical procedure. Additional reports of WNV infection among transfusion recipients quickly followed.
The geographical distribution of the viruses varies with the presence and density of the appropriate vector. A study was done in Jordan for seroprevalence of WNV, 8% of the study subject was found to have a previous WNV infection. In another study conducted in Egypt, the seroprevalence for WNV was 3% among schoolchildren.
In UAE, there have been no previous studies of WNV infections and no clinical reports of the existence of such infections. For this reason, we conducted this study as a pilot study to guide the health policy makers in this area of the world to develop their blood banks screening policy, in spite of the country policy of not importing any blood from abroad.
A total of 500 healthy blood donors who attended the Zayed military hospital from 20 January to 20 January 2005, were included in the study. A 10-mL venous blood sample, obtained from each participant, serum was separated within three hours of collection and stored at -80 °C until further processing.
Nucleic acid extraction was done using the High Pure Viral Nucleic Acid Kit from Roche-Germany (Cat. No. 11 858 874 001) according to the manufacturer's procedure. Purified nucleic acid was eluted in 50 μL elution buffer and stored at -80 °C.
A previously published real-time PCR assay was used.  The LightCycler instrument from Roche (Germany) was used. A cloned synthetic DNA was used as a positive control for WNV (manufactured by TIB MOLBIOL-Germany). All the positive controls gave positive RT-PCR reactions. None of our samples gave any positive RT-PCR reaction.
Our study is the first documentation that West Nile viral infection is not present in the UAE. Humans become infected with West Nile viruses by the bite of an infected Culex mosquito which is not found in the region. Birds are the reservoirs of infection. The absence of the disease in the UAE is not unexpected.
This study is only meant to be a pilot study to act as guidance for further studies. Our methodology used here can only detect an acute stage of infection; however, previously infected people cannot be detected by this method and we need to do serological studies.
With the unprecedented increased population mobility in the form of tourism and business, political borders are no longer barriers against the spread of infections. For this, we need to have more studies among our blood donors, which include serology and molecular screening for this virus.
At the local level, the data should give primary picture for the blood bankers in the area. The absence of the WNV infection among the studied population does not mean it is absent in the UAE. Further studies in different geographical areas of the UAE and with different methodologies are recommended.
| ~ References|| |
|1.||Gea-Banacloche J, Johnson RT, Bagic A, Butman JA, Murray PR, Agrawal AG. West Nile virus: Pathogenesis and therapeutic options. Ann Intern Med 2004;140:545-53. [PUBMED] [FULLTEXT]|
|2.||Komar N, Langevin S, Hinten S, Nemeth N, Edwards E, Hettler D, et al . Experimental infection of North American birds with the New York 1999 strain of West Nile virus. Emerg Infect Dis 2003;9:311-22. [PUBMED] [FULLTEXT]|
|3.||Possible West Nile virus transmission to an infant through breast-feeding- Michigan, 2002. Morb Mortal Wkly Rep 2002;51:877-8. |
|4.||Campbell GL, Marfin AA, Lanciotti RS, Gubler DJ. West nile virus. Lancet Infect Dis 2002;2:519-29. [PUBMED] [FULLTEXT]|
|5.||Landt O, Dehnhardt J, Nitsche A, Milburn G, Carver SD. Rapid detection of the West Nile virus: Rapid cycle real-time PCR: Methods and applications. Microbiology and food analysis. In : Reischl U, Wittwer C, Cockerill F, editors. Springer: Berlin; 2001. |
|This article has been cited by|
||Genetic variants associated with susceptibility of Ashkenazi Jews to West Nile virus infection
| ||N. DANIAL-FARRAN,S. EGHBARIA,N. SCHWARTZ,Z. KRA-OZ,N. BISHARAT |
| ||Epidemiology and Infection. 2014; : 1 |
|[Pubmed] | [DOI]|
||A study of West Nile virus infection in Iranian blood donors
| ||Sharifi, Z., Shooshtari, M.M., Talebian, A. |
| ||Archives of Iranian Medicine. 2010; 13(1): 1-4 |